Analysts Offer Insights on Healthcare Companies: Demant (OtherWILLF) and Notable Labs (NTBL)
Notable Labs Analyst Ratings
Buy Rating Affirmed for Notable Labs Amid Promising Drug Program and Robust PPMP Platform
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Notable Labs (NTBL)
Notable Labs Analyst Ratings
Buy Rating for Notable Labs: Financial Stability and Strategic Advances in AML Clinical Trials
Buy Rating Affirmed for Notable Labs on Strategic Clinical Advancements and Promising PPMP Platform
Notable Labs Analyst Ratings
Maintained Buy Rating on Notable Labs With Adjusted Price Target Amid Drug Setback and PPMP Platform Potential
Keay Nakae's Buy Rating on Notable Labs: Predictive Precision Medicine Platform and Financial Stability as Key Factors
Analysts Are Bullish on These Healthcare Stocks: Notable Labs (NTBL), Karuna Therapeutics (KRTX)
JMP Securities Initiates Coverage On Notable Labs With Market Outperform Rating, Announces Price Target of $13
Notable Labs Analyst Ratings
Vascular Biogenics Cut to Neutral From Buy by Chardan Capital
Vascular Biogenics analyst ratings
Vascular Biogenics (VBLT) Receives a Hold from JonesTrading
Vascular Biogenics Cut to Neutral From Buy by HC Wainwright & Co.
Analysts Offer Insights on Healthcare Companies: Celsion (CLSN), Vascular Biogenics (VBLT) and Portage Biotech Inc (PRTG)
Vascular Biogenics analyst ratings
Vascular Biogenics Price Target Announced at $5.50/Share by Oppenheimer
No Data